ResearcherUniversity of CopenhagenActive in the last 2 years
Søren Brunak
Matched on ORCID iD 0000-0003-0316-5866; OpenAlex author ID A5011862057. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 33
2021: 1 paper · 2022: 1 paper · 2023: 3 papers · 2024: none · 2025: none · 2026: 1 paper
Papers 6
- Validation of a Pretrained Artificial Intelligence Model for Pancreatic Cancer Detection on Diagnosis and Prediagnosis Computed Tomography Scans. Last author DOI 10.1097/rli.0000000000001209↗
- A deep learning algorithm to predict risk of pancreatic cancer from disease trajectories. Co-author DOI 10.1038/s41591-023-02332-5↗
- Plasma YKL-40 is associated with prognosis in patients with metastatic pancreatic cancer receiving immune checkpoint inhibitors in combination with radiotherap… Co-author DOI 10.3389/fimmu.2023.1228907↗
- Pancreatic cancer symptom trajectories from Danish registry data and free text in electronic health records. Last author DOI 10.7554/elife.84919↗
- Randomized Phase II Study of Nivolumab With or Without Ipilimumab Combined With Stereotactic Body Radiotherapy for Refractory Metastatic Pancreatic Cancer (Che… Co-author DOI 10.1200/jco.21.02511↗
- Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review. Co-author DOI 10.1097/mpa.0000000000001762↗
Closest collaborators
The 25 strongest of 33 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jessica Xin Hjaltelin · 4 shared papers, 2022–2023 · strength 0.62
- Paper Plasma YKL-40 is associated with prognosis in patients with metastatic pancreatic cancer receiving immune checkpoint in… DOI 10.3389/fimmu.2023.1228907↗
- Paper Pancreatic cancer symptom trajectories from Danish registry data and free text in electronic health records. DOI 10.7554/elife.84919↗
- Paper A deep learning algorithm to predict risk of pancreatic cancer from disease trajectories. DOI 10.1038/s41591-023-02332-5↗
- Inna Markovna Chen · 3 shared papers, 2022–2023 · strength 0.49
- Paper Plasma YKL-40 is associated with prognosis in patients with metastatic pancreatic cancer receiving immune checkpoint in… DOI 10.3389/fimmu.2023.1228907↗
- Paper Pancreatic cancer symptom trajectories from Danish registry data and free text in electronic health records. DOI 10.7554/elife.84919↗
- Paper Randomized Phase II Study of Nivolumab With or Without Ipilimumab Combined With Stereotactic Body Radiotherapy for Refr… DOI 10.1200/jco.21.02511↗
- Davide Placido · 2 shared papers, 2023–2026 · strength 0.43
- Susann Theile · 2 shared papers, 2022–2023 · strength 0.31
- Paper Plasma YKL-40 is associated with prognosis in patients with metastatic pancreatic cancer receiving immune checkpoint in… DOI 10.3389/fimmu.2023.1228907↗
- Paper Randomized Phase II Study of Nivolumab With or Without Ipilimumab Combined With Stereotactic Body Radiotherapy for Refr… DOI 10.1200/jco.21.02511↗
- Dorte Lisbet Nielsen · 2 shared papers, 2022–2023 · strength 0.31
- Paper Plasma YKL-40 is associated with prognosis in patients with metastatic pancreatic cancer receiving immune checkpoint in… DOI 10.3389/fimmu.2023.1228907↗
- Paper Randomized Phase II Study of Nivolumab With or Without Ipilimumab Combined With Stereotactic Body Radiotherapy for Refr… DOI 10.1200/jco.21.02511↗
- Laura Degand · 1 shared paper, 2026 · strength 0.30
- Julia Sidenius Johansen · 2 shared papers, 2022–2023 · strength 0.30
- Michael Hayden Rosenthal · 2 shared papers, 2021–2023 · strength 0.22
- Brian Matthew Wolpin · 2 shared papers, 2021–2023 · strength 0.22
- Chris Sander · 2 shared papers, 2021–2023 · strength 0.22
- Astrid Zedlitz Johansen · 1 shared paper, 2023 · strength 0.18
- Chen Yuan · 1 shared paper, 2023 · strength 0.13
- Jihye Kim · 1 shared paper, 2023 · strength 0.13
- Chunlei Zheng · 1 shared paper, 2023 · strength 0.13
- Aviv Regev · 1 shared paper, 2023 · strength 0.13
- Peter Kraft · 1 shared paper, 2023 · strength 0.13
- Barbara J. Kenner · 1 shared paper, 2021 · strength 0.09
- William Arthur Hoos · 1 shared paper, 2021 · strength 0.09
- Marcia Irene Canto · 1 shared paper, 2021 · strength 0.09
- David Paul Kelsen · 1 shared paper, 2021 · strength 0.09
- Dana K. Andersen · 1 shared paper, 2021 · strength 0.09
- Stephen Jacob Pandol · 1 shared paper, 2021 · strength 0.09
- Anil K. Rustgi · 1 shared paper, 2021 · strength 0.09
- Sudhir Srivastava · 1 shared paper, 2021 · strength 0.09
- Anirban Maitra · 1 shared paper, 2021 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.